Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term '47 kDa membrane antigen' is ambiguous and refers to different proteins in various bacterial species. Most commonly, it denotes: 1) The 47-kDa membrane lipoprotein (Tp47) from *Treponema pallidum* (syphilis causative agent), which is a penicillin-binding protein with carboxypeptidase and beta-lactamase activities, a major immunogen, and critical for syphilis pathogenesis and diagnosis. 2) The 47-kDa outer membrane antigen/protein (HtrA) from *Orientia tsutsugamushi* (scrub typhus pathogen), which is a serine protease, major immunogen, and key for scrub typhus diagnosis and vaccine research. The term '47 kDa membrane antigen' itself is not a single, universal molecule and requires specific organism context for accurate interpretation and structured data curation.
The mechanism of action varies significantly depending on the specific protein referred to by the ambiguous term. For example, some forms act as enzymes (e.g., penicillin-binding proteins like Tp47 in cell wall synthesis, or serine proteases like O. tsutsugamushi HtrA), while others are targeted by antibodies for pathogen clearance.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 47 kDa membrane antigen (ambiguous term).